- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01270620
Desflurane or Propofol Anesthesia in Elderly Obese Patients Undergoing Total Knee Replacement
Desflurane or Propofol Anesthesia in Elderly Obese Patients Undergoing Total Knee Replacement: A Pilot Assessment of Short-term and Long-term Differences in Outcome
Study Overview
Status
Intervention / Treatment
Detailed Description
Trial Objectives:
This will be a randomized, prospective, single-center, assessor blinded pilot study comparing two different anesthesia techniques in 100 elderly obese patients undergoing primary total knee arthroplasty.
Endpoints:
- The incidence of postoperative delirium as measured by the Confusion Assessment Score. Confusion assessment score will be administered at baseline, one hour after arrival in the post anesthesia care unit and 6-8, 24 and 48 hrs postoperatively.
- Cognitive function as measured by Test for Attentional Performance, Digit-Symbol-Substitution Test, Recal of Digit Span , Well-being Test BF-S, Spielberger State-Trait Anxiety Inventory and the Trail Making Test A and B. Cognitive function tests will be administered at baseline, 6-8 and 48 hrs post operatively. Postoperative Cognitive Dysfunction is defined as a 20% decline of the baseline values.
Intraoperative
- Sensory block (femoral)
- Blood pressure
- Heart rate
- Patient state index values
- Degree of neuromuscular blockade
- Esophageal temperature
- End tidal concentration of CO2
- End tidal concentration of desflurane
- Amount of vasopressors (ephedrine or phenylephrine)
- Amount of intravascular fluid administration
- Dose and mean infusion rates of all IV drugs (propofol)
- Duration of anesthesia
- Duration of surgery
- Time to spontaneous breathing after desflurane/propofol discontinuation
- Time to eye opening after desflurane/propofol discontinuation
- Time to tracheal extubation after desflurane/propofol discontinuation
- Time to following command after desflurane/propofol discontinuation
Post operative
- Nausea and vomiting: one hour after arrival in the post anesthesia care unit and 6-8, 24 and 48 hrs postoperatively
- Pain visual analogue score measured one hour after arrival in the post anesthesia care unit and 6-8, 24 and 48 hrs postoperatively
- Recovery room time
- Amount of local anesthetics (ropivacaine)
- Amount of opioids (Patient controlled analgesia hydromorphone)
Cardiovascular
- B-type natriuretic peptide measured preoperatively and on postoperative days 1 and 2
- N-terminal proB-type natriuretic peptide measured preoperatively and on postoperative days 1 and 2
- Troponin I measured preoperatively and on postoperative days 1 and 2
- Patients will be followed by a blinded investigator for a 2 year period to record the development of cardiac complications defined by a broad composite that included cardiac death and nonfatal myocardial infarction. Cardiac composite including: all-cause mortality, acute myocardial infarction, unstable angina, congestive heart failure, new atrial or ventricular dysrhythmia requiring treatment, and cerebrovascular insult.
Protocol This will be a randomized, prospective, single-center, assessor blinded study comparing two different anesthesia techniques in 100 elderly obese patients undergoing primary total knee arthroplasty. We expect to enroll all patients in a 2 year period.
The study will be performed according to the Declaration of Helsinki principles, and written informed consent will be obtained from each patient. Preoperatively baseline values will be obtained for the cardiovascular, mental status, respiratory and pain outcome measures.
Mental status: During their preoperative visit patients will be given the neuropsychological tests in the following order: 1. Confusion Assessment Method . The confusion assessment method is a screening instrument for delirium consisting of four clinical criteria: (1) acute onset and fluctuating course, (2) inattention, (3) disorganized thinking, and (4) altered level of consciousness. For a person to be considered delirious, both the first and the second criteria and either the third or the fourth criteria have to be present. The confusion assessment method has a high inter-observer reliability (0.8 -1.0), a sensitivity of 94-100%, and a specificity of 90-95%. 2. Modified Mini-Mental State Examination. This extended measure of general cognition was developed to overcome shortcomings of the traditional Mini-Mental State Examination score, specifically its ceiling effects and narrow range of possible scores. The Modified Mini-Mental State Examination will be administered at the preoperative visit to assess the baseline cognitive function of the patient. 3. Computerized Test for Attentional Performance , Digit-Symbol-Substitution Test, Recall of Digit Span, Well-being Test BF-S, Spielberger State-Trait Anxiety Inventory and the Trail Making Test A and B.
Patients will be visited for the first 2 days after surgery or until discharge, whichever came first, and the confusion assessment method will be administered one hour after arrival in the post anesthesia care unit and 6-8, 24 and 48 hrs postoperatively to determine whether the patient is experiencing delirium. Each patient will be interviewed by the same trained research assistant before surgery and during the postoperative visits. We will define the occurrence of delirium as the patient meeting the confusion assessment method criteria for delirium on any of the postoperative assessments. If a patient is positive for delirium, a second member of the research team will be consulted to verify the diagnosis. Cognitive function tests will be administered, 6-8 and 48 hrs post operatively. Postoperative Cognitive Dysfunction is defined as a 20% decline of the baseline values.
Cardiovascular: Preoperative testing will include 12-lead ECG. Blood samples for Natriuretic peptide levels and N-terminal proB-type natriuretic peptide and Troponin I will be obtained at the time of the admission and on postoperative day 1 and day 2. Plasma NT-proB-type natriuretic peptide will be determined using the Elecsys proB-type natriuretic peptide sandwich immunoassay on an Elecsys 2010 (Roche Diagnostics, Basel, Switzerland). Two cut offs for NT-proB-type natriuretic peptide will be selected before the analyses, 300 pg/ml and 600 pg/ml, with a value of less than 300 pg/ml shown to be optimal for ruling out heart failure as a predictor. B-type natriuretic peptide will be determined using immunoradiometric assay kit. Values of B-type natriuretic peptide (pg/mL) 31.0 ± 2.4 are considered normal for patients over 65 years old.
After discharge from the hospital patients will be followed blindly for a 2 year period to record the development of cardiac complications defined by a broad composite that included cardiac death and nonfatal myocardial infarction. Cardiac composite including: all-cause mortality, acute myocardial infarction, unstable angina, congestive heart failure, new atrial or ventricular dysrhythmia requiring treatment, and cerebrovascular insult. Information will be collected at 1, 3, 6, 12, 18 and 24 months after surgery.
Outcome measures and postoperative complications including nausea and vomiting will be recorded by an assessor blinded to the treatment allocation.
Patients will be randomly allocated to one of two treatment groups on the day of surgery using a computer generated assignment. Group D will receive desflurane and group P will receive propofol.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age > 65 years old
- Body mass index > 30 kg/m2
- Undergoing primary total knee arthroplasty surgery
- American society of anesthesiology classification II-III
Exclusion Criteria:
- Patient refusal to participate in the study
- Patient refusal or failure of regional block
- Patients with preexisting neuro-cognitive disorders
- Known intolerance to any of the drugs to be used according to the study protocol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Propofol
Patients will receive propofol as general anesthetics.
|
comparison of the incidence in delirium and post-operative cognitive dysfunction from propofol and desflurane in patients under general anesthesia
|
Active Comparator: Desflurane
Patients will receive desflurane as general anesthetics.
|
comparison of the incidence in delirium and post-operative cognitive dysfunction from propofol and desflurane in patients under general anesthesia
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of Delirium
Time Frame: 48 hours
|
The primary end point was the incidence of postoperative delirium as measured by the Confusion Assessment Method (CAM).
|
48 hours
|
Recall of Digit Span
Time Frame: Change > 20% from baseline to 6-8 hours after surgery
|
• The Digit Span subtest of the Wechsler Adult Intelligence Scale-Revised is a test that requires subjects to repeat a series of digits that have been verbally presented to them both forward and, in a later independent test, reverse order.
It measures attention and working memory
|
Change > 20% from baseline to 6-8 hours after surgery
|
Recall of Digit Span
Time Frame: Change > 20% from baseline to 48 hours after surgery
|
• The Digit Span subtest of the Wechsler Adult Intelligence Scale-Revised is a test that requires subjects to repeat a series of digits that have been verbally presented to them both forward and, in a later independent test, reverse order.
It measures attention and working memory
|
Change > 20% from baseline to 48 hours after surgery
|
Digit Symbol Substitution Test
Time Frame: Change > 20% from baseline to 6-8 hours after surgery
|
• The Digit Symbol Substitution Test (DSST) measures attention, working memory, sustained visual attention and psychomotor speed.
Subjects are given a table that pairs digits and symbols, and asked to decipher a code using the table, completing as many as possible in 90 seconds.
The DSST has been found to be more sensitive than other tests to changes in high-levels of cognition
|
Change > 20% from baseline to 6-8 hours after surgery
|
Digit Symbol Substitution Test
Time Frame: Change > 20% from baseline to 48 hours after surgery
|
• The Digit Symbol Substitution Test (DSST) measures attention, working memory, sustained visual attention and psychomotor speed.
Subjects are given a table that pairs digits and symbols, and asked to decipher a code using the table, completing as many as possible in 90 seconds.
The DSST has been found to be more sensitive than other tests to changes in high-levels of cognition
|
Change > 20% from baseline to 48 hours after surgery
|
Trail Making Part A
Time Frame: Change > 20% from baseline to 6-8 hours after surgery
|
• Trail Making Test is an executive measure of sequencing and cognitive flexibility.
Trail A requires the subject to rapidly sequence a straightforward series.
The scoring for this test is the time in seconds required for completion of the test
|
Change > 20% from baseline to 6-8 hours after surgery
|
Trail Making Part A
Time Frame: Change > 20% from baseline to 48 hours after surgery
|
• Trail Making Test is an executive measure of sequencing and cognitive flexibility.
Trail A requires the subject to rapidly sequence a straightforward series.
The scoring for this test is the time in seconds required for completion of the test
|
Change > 20% from baseline to 48 hours after surgery
|
Trail Making Part B
Time Frame: Change > 20% from baseline to 6-8 hours after surgery
|
• Trail Making Test is an executive measure of sequencing and cognitive flexibility.
Trail B is a more difficult cognitive flexibility task requiring the subject to follow a sequential pattern while shifting cognitive sets and reflects executive functioning, although other cognitive abilities, such as psychomotor speed and visual scanning, are necessary for successful completion of the task.
The scoring for this test is the time in seconds required for completion of the test
|
Change > 20% from baseline to 6-8 hours after surgery
|
Trail Making Part B
Time Frame: Change > 20% from baseline to 48 hours after surgery
|
Trail Making Test is an executive measure of sequencing and cognitive flexibility.
Trail B is a more difficult cognitive flexibility task requiring the subject to follow a sequential pattern while shifting cognitive sets and reflects executive functioning, although other cognitive abilities, such as psychomotor speed and visual scanning, are necessary for successful completion of the task.
The scoring for this test is the time in seconds required for completion of the test
|
Change > 20% from baseline to 48 hours after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
- Time to Spontaneous Breathing After Desflurane/Propofol Discontinuation
Time Frame: first day
|
first day
|
|
- Time to Eye Opening After Desflurane/Propofol Discontinuation
Time Frame: first day
|
first day
|
|
- Time to Tracheal Extubation After Desflurane/Propofol Discontinuation
Time Frame: first day
|
first day
|
|
- Time to Following Command After Desflurane/Propofol Discontinuation
Time Frame: first day
|
first day
|
|
Nausea and Vomiting
Time Frame: 48 hours
|
48 hours
|
|
Recovery Room Time
Time Frame: first day
|
first day
|
|
B-type Natriuretic Peptide
Time Frame: Change from Baseline to day one
|
Change from Baseline to day one
|
|
N-terminal proBNP
Time Frame: Change from baseline to day one
|
Change from baseline to day one
|
|
Troponin I
Time Frame: 2 days
|
Patients who had troponin level > 0.2 ng/mL
|
2 days
|
BNP
Time Frame: Change form baseline to post-operative day 2
|
Change form baseline to post-operative day 2
|
|
ProBNP
Time Frame: Change from baseline to post-operative day 2
|
Change from baseline to post-operative day 2
|
|
Duration of Surgery
Time Frame: Time from Incision to closure of surgery
|
Time from Incision to closure of surgery
|
|
Duration of Anesthesia
Time Frame: Time from induction to extubation
|
Time from induction to extubation
|
|
Amount of Intraoperative Fentanyl
Time Frame: From the anesthesia induction until extubation
|
From the anesthesia induction until extubation
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Hendrikus Lemmens, Stanford University
- Study Director: Pedro Paulo Tanaka, Stanford University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SU-12062010-7277
- IRB: 4593 (Other Identifier: Stanford Instituinal Review Board)
- SPO: 48391 (Other Identifier: Sponsored Project Office Stanford University)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
-
Consorcio Centro de Investigación Biomédica en...Maimónides Biomedical Research Institute of Córdoba; Instituto de Salud Carlos... and other collaboratorsActive, not recruiting
Clinical Trials on propofol
-
Hopital FochCompleted
-
Konkuk University Medical CenterCompletedCoronary Artery Disease | Valvular Heart DiseaseKorea, Republic of
-
University Medical Center GroningenCompletedAnesthesia | Hemodynamic Instability | Interaction | Disorder of Oxygen TransportNetherlands
-
Asan Medical CenterCompletedPopulation Pharmacokinetics/Pharmacodynamics (PK/PD) of Microemulsion Propofol in Healthy VolunteersHealthyKorea, Republic of
-
Tiva GroupMedtronic - MITGCompleted
-
Pontificia Universidad Catolica de ChileCompletedSurgery | Anesthesia | Depth of Anesthesia | NeonateChile
-
Mansoura UniversityCompleted
-
KVG Medical College and HospitalUnknown
-
Acibadem UniversityCompleted